Skip to main content

Table 1 The baseline characteristics of the 26 eligible patients in this study

From: Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study

Baseline characteristics N 26  
Age Median (min–max) 39 (16–70)  
Gender—male N (%) 11(42.3)  
Body weight, kg Median (min–max) 51.9 (37.7–87.7)  
Duration of disease, month Median (min–max) 58 (10–159)  
Extent of UC (Montreal classification)
  Left side colitis (E2) N 10
  Pancolitis (E3) N 16
Disease activity
  pMayo score Median (IQR) 6 (5.25–7)
  MES Median (IQR) 2 (2–2)
Concomitant medication
  5-aminosalicylic acid N (%) 23 (88.4)
  Corticosteroid N (%) 8 (30.7)
  Immunosuppressant N (%) 11 (42.3)
  Anti-TNF-alpha agent N (%) 5 (19.2)
Biomarker
  FC (mg/kg) Median (IQR) 11,294.5 (5116.75–18,755.25)
  WBC count Median (IQR) 6350 (4935–7945)
  CRP (mg/dL) Median (IQR) 0.58 (0.1–1.39)